Mefron Technologies has secured its maiden private equity investment from Motilal Oswal Principal Investments and India SME Investments, marking a key milestone in the company's expansion journey.
17hon MSN
Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say
By Rishika Sadam MUMBAI, Feb 25 (Reuters) - Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results